Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Meta’s Threads becomes most rapidly downloaded app in history

    04:18

  • Now Playing

    How Lequimbi could slow the progress of Alzheimer’s disease

    03:41

  • UP NEXT

    U.S. economy added 209,000 jobs in June

    03:08

  • Officials clarify where cocaine was found in the White House

    04:13

  • Former U.S. officials held secret talks with Russia about ending war in Ukraine

    03:51

  • NYC law requires companies to prove A.I. hiring software is not racist or sexist

    02:08

  • Thousands of flights canceled or delayed amid extreme weather

    03:39

  • U.S. Navy prevented Iranian warships from seizing two oil tankers in international waters

    03:27

  • Deadly Russia missile strike hits civilian infrastructure in western Ukraine

    03:54

  • Cocaine was found in ‘heavily traveled’ part of West Wing, WH says

    03:31

  • New details on Mar-a-Lago classified documents search warrant emerge

    04:15

  • Israel ends its two day military operation in the occupied West Bank

    03:44

  • NAACP challenges legacy admissions after Supreme Court’s ruling on affirmative action

    02:52

  • King Charles III marks second coronation in Scotland

    02:59

  • Prigozhin appears to call for support after rebellion against Moscow

    03:49

  • Thousands of Southern California hotel workers on strike

    02:26

  • How online scammers are luring victims with romantic relationships

    03:31

  • Kevin Spacey sexual offense trial underway in London

    04:12

  • How to safely celebrate the Fourth of July amid extreme weather

    05:18

  • Fewer arrests made in protests over fatal police shooting in France

    04:01

The FDA has fully approved a new drug called Lequembi that could potentially slow down the advancement of early stage Alzheimer’s disease. NBC News’ Dr. John Torres breaks down what the FDA is saying about the drug and whether there are any risks involved in taking it. 

Source

Leave a Reply